New search    Hide text from Guidelines

Antiseptic and antiinfective preparations for systemic use specifically used in urinary tract infections, see J01.
Antiinfectives for systemic use, see group J.
Gynecological antiinfectives and antiseptics, see G01.

This group comprises urological preparations other than antiseptics and antiinfectives.

Alprostadil intracavernosal injection for treatment of erectil dysfunction is classified here, while formulations used to maintain the patency of the ductus arteriosis in neonates are classified in C01EA01.
Combinations of papaverine and phentolamine for intracavernous administration are classified under G04BE30 - combinations. Combinations of phentolamine and aviptadil (polypeptide) are classified under G04BE30 - combinations.
Phosphodisesterase inhibitors also indicated for pulmonary arterial hypertension (PAH) are classified in this group. Other agents used for treatment of PAH are classified in C02KX or in B01AC. Combinations of ambrisentan or macitentan and phosphodisesterase inhibitors are classified in C02KX - Antihypertensives for pulmonary arterial hypertension.
Combinations of alpha-adrenoreceptor antagonists or testosterone-5-alpha reductase inhibitors and phosphodisesterase inhibitors used in benign prostatic hypertrophy are classified in G04CA or G04CB, respectively.

ATC code	Name	DDD	U	Adm.R	Note
G04BE01	alprostadil	20	mcg	P
		0.25	mg	urethral
G04BE02	papaverine
G04BE03	sildenafil	50	mg	O
G04BE04	yohimbine	15	mg	O
G04BE06	moxisylyte
G04BE07	apomorphine	2	mg	SL
G04BE08	tadalafil	10	mg	O
G04BE09	vardenafil	10	mg	O
G04BE10	avanafil	0.1	g	O
G04BE11	udenafil
G04BE30	combinations
G04BE52	papaverine, combinations

List of abbreviations